Morphological alterations and intratubular lipid inclusions as indicative of spermatogenic damage in cimetidine-treated rats.
Doses of cimetidine (50 mg/kg b/w) were administered to adult male Wistar rats over 52 consecutive days. Besides plasma testosterone levels, morphological and morphometric aspects of the seminiferous tubules as well as histochemical analysis of the lipid content by oil red O were emphasized. Abnormal tubules exhibiting disorganization of their cellular association, loss of germ cells, and multinucleated giant spermatids were usually found. Significant reductions of testis weight and tubular diameter at specific stages (VII-IX), as well as lack of contact between Sertoli cells and spermatids in tubules at stage IX, suggest a possible interference of cimetidine on the histoarchitecture of the seminiferous epithelium. The dense concentration of lipid inclusions in tubules at postspermiation stages indicates phagocytosis and degradation of germ cells. Since no change in serum testosterone levels was verified in cimetidine-treated rats, the authors could not exclude the possibility that besides an antiandrogenic effect, other biochemical factors necessary for normal spermatogenesis could be involved in the testicular alterations.
Sasso-Cerri
E
E
Department of Morphology, Federal University of São Paulo, Brazil. scerri.morf@epm.br
Giovanoni
M
M
Hayashi
H
H
Miraglia
S M
SM
D000726:Androgen Antagonists / Q000633:toxicity; D000818:Animals; D000897:Anti-Ulcer Agents / Q000633:toxicity; D002927:Cimetidine / Q000633:toxicity*; D050356:Lipid Metabolism; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012671:Seminiferous Tubules / Q000187:drug effects / Q000473:pathology; D013091:Spermatogenesis / Q000187:drug effects*; D013737:Testis / Q000187:drug effects* / Q000473:pathology; D013739:Testosterone / Q000378:metabolism
D000726:Androgen Antagonists; D000897:Anti-Ulcer Agents; D013739:Testosterone; D002927:Cimetidine